IL-6/SOLUBLE IL-6-RECEPTOR (SIL-6R) MEDIATE 2 DISTINCT SIGNALING PATHWAYS IN OSTEOBLASTS THROUGH GP130

被引：0
|
作者：
NISHIMURA, R
YASUKAWA, K
MUNDY, GR
YONEDA, T
机构：
[1] UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX 78284
[2] TOSO,KANAGAWA,JAPAN
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1995年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S158 / S158
页数：1
相关论文
共 50 条
  • [21] Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling
    Misato Hashizume
    Masahiko Mihara
    Rheumatology International, 2009, 29 : 397 - 401
  • [22] PARATHYROID-HORMONE (PTH) EXCESS IS ASSOCIATED WITH INCREASED INTERLEUKIN-6 (IL-6) AND SOLUBLE IL-6 RECEPTOR (SIL-6R) PRODUCTION
    RUSINKO, R
    YIN, JJ
    YEE, J
    SAAD, T
    MUNDY, GR
    GUISE, TA
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S500 - S500
  • [23] sgp130Fc inhibits IL-6 trans-signaling depending on local sIL-6R levels and IL6-receptor expression
    Thaiss, W. M.
    Rose-John, S.
    Scheller, J.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 : 101 - 101
  • [24] EXPRESSION OF THE INTERLEUKIN-6 (IL-6), IL-6 RECEPTOR, AND GP130 GENES IN ACUTE-LEUKEMIA
    INOUE, K
    SUGIYAMA, H
    OGAWA, H
    YAMAGAMI, T
    AZUMA, T
    OKA, Y
    MIWA, H
    KITA, K
    HIRAOKA, A
    MASAOKA, T
    NASU, K
    KYO, T
    DOHY, H
    HARA, J
    KANAMARU, A
    KISHIMOTO, T
    BLOOD, 1994, 84 (08) : 2672 - 2680
  • [25] IL6 SIGNALING THROUGH IL6 RECEPTOR AND RECEPTOR-ASSOCIATED SIGNAL TRANSDUCER, GP130
    TAGA, T
    RESEARCH IN IMMUNOLOGY, 1992, 143 (07): : 737 - 739
  • [26] IL-6, sIL-6R/IL-6 complex and insulin-resistance in obese children
    De Filippo, Gianpaolo
    Rendina, Domenico
    Campanozzi, Angelo
    Moccia, Filomena
    Rocco, Vincenzo
    Mossetti, Giuseppe
    Melone, Maria Rita
    Spinosa, Enrico
    Mantovani, Massimo Pettoello
    HORMONE RESEARCH, 2006, 65 : 51 - 51
  • [27] Shedding of non-functional interleukin-6 (IL-6) receptor (IL6R or gp80) results in the activation of gp130 mediated signaling in human osteoblasts.
    Vermes, C
    Roebuck, KA
    Fritz, EA
    Hanyecz, A
    Glant, TT
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S112 - S112
  • [28] Clazakizumab (CLZ, Anti-IL-6 Antibody) and Tocilizumab (TCZ, Anti-IL-6 Receptor [r] Antibody) Treatments Differentially Affect IL-6/IL-6R Signaling by Modulating Soluble IL-6R (sIL-6R) and gp130 (sgp130) in Kidney Transplant Patients (KTx Pts) Treated for Chronic Antibody-Mediated Rejection (cABMR).
    Shin, B.
    Ge, S.
    Petrosyan, A.
    Ammerman, N. F.
    Vo, A. A.
    Jordan, S. C.
    Toyoda, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 452 - 452
  • [29] Teleost IL-6 promotes antibody production through STAT3 signaling via IL-6R and gp130
    Kaneda, Mitsuru
    Odaka, Tomoyuki
    Suetake, Hiroaki
    Tahara, Daisuke
    Miyadai, Toshiaki
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2012, 38 (02): : 224 - 231
  • [30] Effect of IL-18 on the release of IL-6 and its soluble receptors:: sIL-6Rα and sgp130 by human neutrophils
    Jablonska, E
    Jablonski, J
    IMMUNOLOGICAL INVESTIGATIONS, 2002, 31 (3-4) : 159 - 167
12345